Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(18 sites)
United States
Sutter Health Alta Bates, Berkeley, California City of Hope, Duarte, California University of California Los Angeles, Los Angeles, California University of California Davis Medical Center, Sacramento, California Stanford University, Stanford, California